The acquisition of Everest Biotech will broaden the LSBio offering of over 500,000 monoclonal and polyclonal
primary antibodies to include virtually every protein in the proteome.
During recent outbreaks of EVD in West Africa, passive immunotherapy with convalescent plasma containing polyclonal
antibodies from recovered patients was used as an effective treatment.
Neovii is a global leader in polyclonal
antibody immunosuppressive therapy used in organ transplantation and hematology/oncology.
There are validated commercial fecal elastase ELISA kits using monoclonal (ScheBo Biotech) or polyclonal
antibodies (Bioserv Diagnostic) .
To determine whether our insights were sensitive to the method used for distinguishing between classes of heterogeneous infections, we used a newly described method (classifier of tandem repeats [ClassTR]) (8), which uses 24-loci mycobacterial interspersed repetitive units-variable number of tandem repeats (MIRU-VNTR) data to distinguish polyclonal
and clonal infections, and we compared these findings with an analysis based on the standard threshold-based approach (9).
reported reactivity of polyclonal
PAX8 antibody (pPAX8) in nonneoplastic B cells and mature B-cell neoplasms, but not with monoclonal PAX8 (mPAX8) antibody within these tissues, and proposed cross-reactivity of the polyclonal
commercially available PAX8 antibody with B-cell marker PAX5 .
All biopsies showed strong positivity for the polyclonal
antibody for T pallidum (Figure, C).
* Histology and Cytology market includes Flow Cytometers, Monoclonal Antibodies, Polyclonal
Antibodies, Tissue Typing Reagents and Immunmodulators.
Ancaster, Canada, April 22, 2015 --(PR.com)-- Typically, laboratories choose polyclonal
antibodies over monoclonal antibodies because over their wide range of benefits.
Emerging data, combined with concerns about the accuracy of polyclonal
GLP-1 receptor antibody staining, suggest that there may be little to no risk for treatment-related pancreatitis or pancreatic cancer in patients with diabetes, Dr.
B cell lymphocytosis (PPBL) is a rare and presumably nonmalignant lymphoproliferative disorder diagnosed predominantly in women [1, 2], although a few men have also been diagnosed with this condition [3-5].
Here we report on the demonstration of putative human TMPOdelta and epsilon by immunoblotting of human cell lines using a newly prepared polyclonal
antiserum against the common N-terminal region of TMPO.